BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Onyx Pharmaceuticals, Inc. Release: Phase 3 Data on Regorafenib Met Primary Endpoint Showing Significant Improvement in Progression-Free Survival in Patients with GIST

  June 4, 2012

   · 

  5 min read
• Business

  ShangPharma and Eli Lilly and Company Celebrate 10 Years of Partnership

  June 4, 2012

   · 

  2 min read
• China Biologic Products to Attend Jefferies and Co. Healthcare Conference on June 7, 2012 in New York

  June 4, 2012

   · 

  1 min read
• Deals

  Akron General Medical Center Acquires Both Brainsuite® iMRI and iCT - BrainLAB AG Technology to be Part of Neuroscience Institute

  June 4, 2012

   · 

  4 min read
• Business

  Oncology Services International Names Richard Hall as President and CEO

  June 4, 2012

   · 

  2 min read
• Drug Development

  Pharmacyclics, Inc. Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at American Society of Clinical Oncology (ASCO) Annual Meeting

  June 4, 2012

   · 

  6 min read
• BioMidwest

  Oklahoma Bioscience Association to Exhibit at 2012 Biotechnology Industry Organization (BIO) International Convention, booth 809, Jun 18 - 21, 2012, in Boston MA, US

  June 4, 2012

   · 

  1 min read
• Drug Development

  Esperance Pharmaceuticals, Inc. Presents Results From Phase 1 Study of EP-100 in Advanced, Refractory LHRH-Receptor Expressing Solid Tumors at American Society of Clinical Oncology

  June 4, 2012

   · 

  4 min read
• Biotech Bay

  CytRx Corporation to Hold Conference Call Today at 10:00 a.m. Eastern Time to Discuss Favorable Results from INNO-206 Clinical Trial in Soft Tissue Sarcoma

  June 4, 2012

   · 

  1 min read
• Drug Development

  Millennium: The Takeda Oncology Company Release: Clinical Data Presented on Orteronel (TAK-700) Without Steroids in Non-Metastatic Prostate Cancer

  June 4, 2012

   · 

  1 min read